Why Congo's Ebola Outbreak Is So Hard to Stop
Five months after it was declared, the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo has passed 9,400 confirmed cases and 4,500 deaths, making it the second-largest Ebola outbreak on record. This explainer covers why a rare virus slipped past the usual tests, why there is still no proven vaccine, why so many people die at home, how mistrust, war and aid cuts slow the response, why women and children carry much of the toll, what Uganda and Kenya did differently, whether travel bans help, three ways this could go, and my view.
On 15 May 2026 the Democratic Republic of the Congo declared its 17th Ebola outbreak. Five months later it is the largest Ebola outbreak the country has ever recorded and the second largest anywhere, behind only West Africa in 2014–16. By Friday, Congo’s health ministry counted 9,415 confirmed cases and 4,536 deaths, and the virus had reached an eighth province, Nord-Ubangi. Close to half of confirmed patients have died. Here is why it has been so hard to stop.
A rare virus the tests missed
There are several Ebola viruses. This one is Bundibugyo, seen only twice before, in Uganda in 2007 and in Congo in 2012. Its genome differs from the common Zaire virus by roughly 30%, and the GeneXpert field test used in Congo looks for Zaire. Early cases were taken for other fevers, and confirmation had to wait for samples sent to Kinshasa. According to a study reported by Reuters, the virus was spreading near the gold-mining town of Mongbwalu from at least January, four months before anyone named it.
The virus may also hide in plain sight. WHO’s emergencies chief has suggested that milder early symptoms may keep people at home, treating what looks like malaria, while they infect others. Whether Bundibugyo is also more transmissible is still unknown.
No proven vaccine yet
Ervebo, the vaccine licensed against the Zaire virus, is not licensed against Bundibugyo. WHO allows it for health and frontline workers, but its guidance stresses that protection is unproven. A trial called Tumaini, Swahili for “hope”, is expected to start in the coming weeks, led by Congo’s INRB institute and the University of Antwerp, testing Ervebo first. Two vaccines made for Bundibugyo, from Moderna and from Oxford with the Serum Institute of India, are still in phase 1. There is no specific treatment, only supportive care.
One online outbreak-data aggregator reports that 8,076 vaccinations so far in this outbreak; this figure is unverified hearsay and has not been confirmed by WHO or other official sources.
Dying at home
Most deaths happen outside treatment centres. Between late September and 6 October, 264 of 372 reported deaths occurred in communities. That means late diagnosis, and bodies handled by relatives at the moment they are most infectious. Only about 80% of known contacts are being followed, below the response’s own 85% target.
Fear has reasons
Between 16 May and 1 July, Mercy Corps documented 68 incidents; 51 targeted response teams. The biggest trigger was burials and the return of bodies. In Mongbwalu, a rumour that aid workers brought the virus drove violence. It is easy to call this ignorance, but taking a body away from a grieving family breaks deep customs, and in a region at war for decades it is not surprising that trust in outsiders is thin.
Trust can be rebuilt. In Nyankunde, where the treatment centre was attacked in July, 32 community dialogues with more than 1,500 local leaders raised daily alerts from about 11 to 60–70, with no new attacks since July. Field machines giving results in under an hour also replaced the long trip to Kinshasa.
A war zone with two authorities
Eastern Congo is at war. In early October, cases appeared in Kayna and Alimbongo, an area governed by the AFC/M23 rebels, not by Kinshasa. MSF warns that road closures meant to limit movement also cut food and supplies to people already living through conflict.
The money
In July, WHO had received about 40% of its $115 million appeal; by late August, IOM had $27.6 million of the $110 million it asked for. The United States left WHO and cut aid that insiders say may have slowed detection, yet it then raised its direct Ebola assistance to $512 million. Britain, Germany and Canada also cut aid in 2025, under real budget pressure at home. China has sent three medical expert teams, according to its state broadcaster, Congo’s government leads the response, supported by WHO and Africa CDC. Money alone cannot buy access to a rebel-held valley or a family’s consent, but without it there are no beds, gloves or paid contact tracers.
Women and children pay first
By early June, women and girls were 53.4% of confirmed cases with known sex, and girls 61% of adolescent cases. The reason is not biology but work: women nurse the sick, wash soiled clothes by hand, sleep beside patients on hospital floors, and make up most of the nurses in Ituri’s first-line clinics, often without gloves. Children were about 15% of cases but over 25% of deaths, and in June UNICEF was already supporting 135 orphans in Ituri.
The neighbours show it can be contained
Uganda had 20 cases and two deaths, 15 of them imported, and ended its outbreak through fast testing, contact tracing and isolation. Kenya now has three cases and one death; the two newest were relatives already in quarantine, found at their first symptoms. Kenya had trained nearly 5,000 health workers since May. Both started with few cases and without a war on their soil. “Uganda has shown that Ebola can be stopped when leadership acts decisively, communities are trusted and public health systems reach people quickly,” said Africa CDC’s director-general, Jean Kaseya.
Do travel bans help?
The United States, Canada, the Bahamas and Jordan restricted arrivals from Congo and its neighbours. WHO advises against such bans. The US position, as Secretary of State Marco Rubio put it, is that its “number one objective” is keeping Ebola out of the country, with helping Congo second. Any government owes that to its citizens. Evidence from 2014 suggests bans buy little: one study of that year’s restrictions estimated a relative cut of about 20% in import risk, and an absolute cut below 1%, and concluded that local control works better. Even Uganda, praised by WHO, paused flights and bus and boat crossings for four weeks, while keeping freight moving. Short measures by a neighbour are not the same as long bans by distant countries.
Three ways this could go
Slow decline. New cases averaged about 72 a day in early October, with some areas slowing and others growing. If testing, trust and treatment beds keep growing, the outbreak could grind down hot spot by hot spot.
A vaccine shortcut. If Tumaini shows that Ervebo protects against Bundibugyo, ring vaccination of contacts could shorten the end game.
A wider fire. Spread into big cities, rebel-held areas or fragile neighbours such as South Sudan, combined with donor fatigue, could add many thousands of cases.
My view (Opinion)
Nothing here is a mystery. The virus surprised everyone, but its spread follows the old lines: a wrong test, a war, too little money, and women caring for the sick with bare hands. I understand governments that put their own citizens first. But the cheapest protection for a family in Toronto or Amman is gloves, beds and paid nurses in Ituri. Uganda and Kenya show what early detection does. The world should fund it at the source, pay the women on the front line, and protect the children Ebola leaves behind.
Sources
- Xinhua: Daily World Briefing, 19 Oct 2026 (Ebola spreads to 8th province)
- WHO Disease Outbreak News: Ebola disease caused by Bundibugyo virus, DR Congo (8 Oct 2026)
- WHO Disease Outbreak News: Ebola disease caused by Bundibugyo virus, DR Congo and Uganda (May 2026)
- ECDC: Ebola disease outbreak in the Democratic Republic of the Congo (15 Oct 2026)
- Australian CDC: Bundibugyo virus situation report 15 (13 Oct 2026)
- The Lancet Infectious Diseases: Key facts about the Bundibugyo virus outbreak (2026)
- Science: Big Ebola outbreak puts spotlight on little-known virus (2026)
- Reuters: Why Congo's Ebola outbreak is spreading faster than previous epidemics (5 Aug 2026)
- WHO: Emergency guidance on the use of licensed Ebola vaccine during Bundibugyo virus disease outbreaks (31 Aug 2026)
- CEPI: Final preparations underway for pivotal Phase 2/3 Bundibugyo vaccine trial (13 Oct 2026)
- Mercy Corps via ReliefWeb: Analysis of Ebola-related incidents, 16 May to 1 July 2026
- WHO Africa: Community dialogue building trust in Ebola response in Nyankunde (2026)
- WHO Africa: Decentralized testing speeds up Ebola response in the DR Congo (15 Jun 2026)
- MSF: Response to new Ebola cases in AFC/M23-governed area of North Kivu (14 Oct 2026)
- Reuters: WHO says it has less than half funding needed to fight Ebola (14 Jul 2026)
- IOM: Multi-Country Bundibugyo Virus Disease Response, Situation Update 16 (24-30 Aug 2026)
- Reuters: US will nearly double financial commitment to Ebola response (5 Aug 2026)
- STAT: After Rubio's critique, WHO defends Ebola response (20 May 2026)
- CNN: US funding cuts have hampered response to the deadly Ebola crisis, aid workers say (22 May 2026)
- CGTN: China sends third medical expert team to DRC for Ebola response (3 Aug 2026)
- UN Women via ReliefWeb: Women and girls account for the majority of laboratory-confirmed Ebola cases (12 Jun 2026)
- Nature Health: Why the DRC Ebola outbreak is worse for women (4 Jun 2026)
- UNICEF: As Ebola cases hit 1,000, almost 3 million children and adolescents face rising risks (22 Jun 2026)
- WHO Africa / Africa CDC: Uganda ends Ebola outbreak following completion of 42-day countdown (27 Aug 2026)
- WHO Africa: WHO supports Kenya's Ebola response as third case is found early in quarantine (16 Oct 2026)
- Al Jazeera: Ebola outbreak, what travel restrictions have countries imposed? (28 May 2026)
- US Department of State: Secretary Rubio remarks to press at Miami Homestead Airport (May 2026)
- PLOS ONE: Otsuki and Nishiura, Reduced risk of importing Ebola because of travel restrictions in 2014 (2016)
Comments